Is sugammadex economically viable for routine use

Current Opinion in Anaesthesiology

Volumn 25, Issue 2, 2012, Pages 217-220

  Fuchs Buder, Thomas ^a   Meistelman, Claude ^a   Schreiber, Jan U ^b  

^a UNIVERSITÉ DE LORRAINE   (France)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Neostigmine; Pharmacoeconomics; Residual blockade; Sugammadex

Indexed keywords

GLYCOPYRRONIUM BROMIDE; NEOSTIGMINE; ROCURONIUM; SUGAMMADEX; SUXAMETHONIUM;

COST EFFECTIVENESS ANALYSIS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; EVIDENCE BASED PRACTICE; EXTUBATION; HUMAN; PRIORITY JOURNAL; REVIEW;

ANDROSTANOLS; COST-BENEFIT ANALYSIS; GAMMA-CYCLODEXTRINS; HUMANS; NEUROMUSCULAR BLOCKADE;

EID: 84858962129     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32834f012d     Document Type: Review

References (17)

1. Fuchs-Buder T, Claudius C, Skovgaard LT, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: The Stockholm revision. Acta Anaesthesiol Scand 2007; 51:789-808. (Pubitemid 47063004)
2. Plaud B, Debaenne B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112:1013-1022. Excellent review of incidence, clinical consequences and treatment of residual paralysis.
3. Kopman AF, Zank LM, Ng J, Neuman GG. Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: Should quantitative assessment of neuromuscular function be mandatory? Anesth Analg 2004; 98:102-106. (Pubitemid 38029854)
4. Kirkegaard H, Heier T, Caldwell JE. Efficacy of tactile-guided reversal of cisatracurium induced neuromuscular block. Anesthesiology 2002; 96:45-50. (Pubitemid 34032480)
5. Blobner M, Eriksson LI, Scholtz J, et al. Reversal of rocuronium induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: Results of a randomised, controlled trial. Eur J Anaesthesiol 2010; 27:874-881. The article assessed efficiency and predictability of sugammadex reversal and neostigmine reversal.
6. Mirakhur RK. Sugammadex in clinical practice. Anaesthesia 2009; 64 (Suppl 1):45-54.
7. White PF. Facilitating recovery from anesthesia: Assessing the costs and benefits of anesthetic drugs. Anesth Analg 2010; 10:273-275.
8. Paton F, Paulden M, Chambers D, et al. Sugammadex compared with neostigmine/ glycopyrrolate for routine reversal of neuromuscular block: A systematic review and economic evaluation. Br J Anaesth 2010; 105:558-567. First systematic pharmacoeconomic evaluation of sugammadex routine reversal.
9. Baumgart A, Denz C, Bender H, et al. Simulation-based analysis of novel therapy principles. Effects on the efficiency of operating room processes. (in German). Anaesthesist 2009; 58:180-186.
10. Raft J, Chenot E-D, Longrois D, Meistelman C. Analysis of neuromuscular blocking drugs and sugammadex expenses, one year after its introduction in routine clinical practice (letter, in French). Ann Fr Anesth Reanim 2011; 30:758-759.
11. Chambers D, Paulden M, Paton F, et al. Sugammadex for reversal of neuromuscular block after rapid sequence intubation: A systematic review and economic assessment. Br J Anaesth 2010; 105:568-575.
12. Schaller SJ, Fink H, Ulm, Blobner M. Sugammadex and neostigmine dosefinding study for reversal of shallow residual neuromuscular block. Anesthesiology 2010; 113:1054-1060.
13. Eleveld DJ, Kuizenga K, Proost JK, Wierda JM. A temporary decrease in twitch response during reversal or rocuronium-induced muscle relaxation with small dose of sugammadex. Anesth Analg 2007; 104:582-584. Comprehensive explication of sugammadex mechanism of action and risk of underdosing.
14. Drobnik L, Sparr HJ, Thörn SE, et al. A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular block with sugammadex. Eur J Anaesthesiol 2010; 27:866-873.
15. Fuchs-Buder T. Less is not always more: Sugammadex and the risk of underdosing. Eur J Anaesthesiol 2010; 27:849-854.
16. Dexter F, Coffin S, Tinker JH. Decreases in anesthesia-controlled time cannot permit one additional surgical operation to be reliably scheduled during the workday. Anesth Analg 1995; 81:1263-1268.
17. Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107:130-137.